Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 pseudogene 13 (RPL7P13) is a processed pseudogene corresponding to the ribosomal protein L7 gene. It does not encode a functional protein and is not known to have a biological role. Pseudogenes like RPL7P13 are remnants of protein-coding genes that have lost their ability to code for proteins due to accumulation of disabling mutations. RPL7P13 is one of several pseudogenes related to the functional ribosomal protein L7 gene, which participates in ribosome structure and function, but RPL7P13 itself is not functional and is not considered a therapeutic target[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 13 (RPL7P13).